Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-020920

Chief Legal Officer acquired 9,018 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Ali-Jackson Kamil Chief Legal Officer 2018-03-16 Other acquisition +9,018 87,677 D
Loading xslF345X03/doc4.xml…